Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 14, 2017

View Archived Issues

Sutro and Celgene refocus their immune-oncology collaboration

Hanyang University discovers novel SAPK1a, SAPK1b and SAPK1c inhibitors

NEOMED Institute presents bromodomain and extraterminal domain protein inhibitors

New Bruton tyrosine kinase inhibitors patented by InnoCare Pharma

Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patents bile acid receptor antagonists

Novel S1P5 agonists identified at Ono Pharmaceutical

BMTP-11 demonstrates efficacy in preclinical models of human osteosarcoma

Heterozygous Gnal knock-out mice as a novel model of DYT25-associated dystonia

First-in-human results for CART-EGFRvIII cell therapy in patients with recurrent glioblastoma

Rat HCV-related hepacivirus used to create model of HCV infection

Shire's Onivyde approved in Canada for metastatic adenocarcinoma of the pancreas

LipimetiX Development product given U.S. orphan status for homozygous familial hypercholesterolemia

Actelion's cadazolid named orphan drug in the U.S. for pediatric clostridium difficile infection

FDA grants DCC-2618 orphan status for glioblastoma multiforme and anaplastic astrocytomas

iPS Academia Japan and Tokyo Women's Medical University sign license agreement

NovoBiotic Pharmaceuticals is awarded SBIR phase I NIH NIAID grant

NIH awards three grants to researchers at Albert Einstein College of Medicine

Diamyd Medical and Cardiff University to collaborate on study of Diamyd diabetes vaccine

Inotersen and IONIS-FB-LRx to be independently developed by Ionis Pharmaceuticals

Akonni Biosystems is awarded NIH contract

First patient dosed in phase I extension trial of fimaCHEM

Klaria and Purdue Pharma to codevelop KL-00514

Protea enters collaboration research agreement with Massachusetts General Hospital

PreveCeutical Medical signs research collaboration letter of intent with UniQuest

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...